Clarivate (NYSE:CLVT – Get Free Report) is anticipated to release its earnings data before the market opens on Wednesday, February 19th. Analysts expect Clarivate to post earnings of $0.20 per share and revenue of $660.13 million for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.
Clarivate Price Performance
Shares of CLVT opened at $4.89 on Wednesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.88 and a current ratio of 0.88. The firm has a market cap of $3.47 billion, a PE ratio of -2.45 and a beta of 1.17. Clarivate has a twelve month low of $4.25 and a twelve month high of $9.60. The firm’s 50 day moving average price is $5.23 and its 200 day moving average price is $5.88.
Clarivate announced that its board has initiated a stock repurchase plan on Monday, December 16th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to reacquire up to 12.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its shares are undervalued.
Wall Street Analyst Weigh In
View Our Latest Research Report on CLVT
Insider Transactions at Clarivate
In related news, Director Michael J. Angelakis bought 765,000 shares of the business’s stock in a transaction that occurred on Friday, November 22nd. The stock was purchased at an average cost of $5.19 per share, for a total transaction of $3,970,350.00. Following the purchase, the director now directly owns 3,465,000 shares in the company, valued at $17,983,350. This trade represents a 28.33 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 22.77% of the stock is currently owned by corporate insiders.
About Clarivate
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
See Also
- Five stocks we like better than Clarivate
- The Role Economic Reports Play in a Successful Investment Strategy
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.